Log In
Print
BCIQ
Print
Print this Print this
 

99mTc-MIP-1404 (99mTc-trofolostat)

  Manage Alerts
Collapse Summary General Information
Company Progenics Pharmaceuticals Inc.
DescriptionTechnetium-99m-labeled small molecule targeting prostate-specific membrane antigen (PSMA; FOLH1; GCPII)
Molecular Target Prostate-specific membrane antigen (PSMA) (FOLH1) (GCPII)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPhase II
Standard IndicationCancer, Diagnostic
Indication DetailsDetect prostate cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today